APOE and Alzheimer disease: For instance, while Sea Hero Quest (Coughlan et al., 2019) showed to be helpful in discriminating between subjects with and without a genetic risk for sporadic AD (i.e., APOE ε3ε4 carriers vs non-carriers), the object location task (Castegnaro et al., 2022), SOIVET (Da Costa et al., 2022), navigation test suite (Laczó et al., 2022), SCT-VR (Park, 2022), and the VReoT (Caffò et al., 2012) showed an adequate capacity to discriminate between MCI and healthy participants.